FR2615190B1 - Nouvelles arylcarbamoyl-3 aminomethyl-5 oxazolidines ainsi que leurs sels avec des acides pharmaceutiquement compatibles, leur methode de preparation et leur application pharmaceutique - Google Patents

Nouvelles arylcarbamoyl-3 aminomethyl-5 oxazolidines ainsi que leurs sels avec des acides pharmaceutiquement compatibles, leur methode de preparation et leur application pharmaceutique

Info

Publication number
FR2615190B1
FR2615190B1 FR8706890A FR8706890A FR2615190B1 FR 2615190 B1 FR2615190 B1 FR 2615190B1 FR 8706890 A FR8706890 A FR 8706890A FR 8706890 A FR8706890 A FR 8706890A FR 2615190 B1 FR2615190 B1 FR 2615190B1
Authority
FR
France
Prior art keywords
oxazolidines
arylcarbamoyl
aminomethyl
salts
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8706890A
Other languages
English (en)
Other versions
FR2615190A1 (fr
Inventor
Christian Jarry
Jean-Jacques Bosc
Claude Feniou
Emmanuel Panconi
Bernard Vaugien
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cortial SA
Original Assignee
Cortial SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cortial SA filed Critical Cortial SA
Priority to FR8706890A priority Critical patent/FR2615190B1/fr
Priority to FR888806253A priority patent/FR2631029B2/fr
Priority to EP88450019A priority patent/EP0294307B1/fr
Priority to DE3850304T priority patent/DE3850304T2/de
Priority to AT88450019T priority patent/ATE107637T1/de
Priority to ES88450019T priority patent/ES2056121T3/es
Publication of FR2615190A1 publication Critical patent/FR2615190A1/fr
Application granted granted Critical
Publication of FR2615190B1 publication Critical patent/FR2615190B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/26—Oxygen atoms attached in position 2 with hetero atoms or acyl radicals directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/28—Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FR8706890A 1987-05-14 1987-05-14 Nouvelles arylcarbamoyl-3 aminomethyl-5 oxazolidines ainsi que leurs sels avec des acides pharmaceutiquement compatibles, leur methode de preparation et leur application pharmaceutique Expired FR2615190B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR8706890A FR2615190B1 (fr) 1987-05-14 1987-05-14 Nouvelles arylcarbamoyl-3 aminomethyl-5 oxazolidines ainsi que leurs sels avec des acides pharmaceutiquement compatibles, leur methode de preparation et leur application pharmaceutique
FR888806253A FR2631029B2 (fr) 1987-05-14 1988-05-05 Nouvelles arylcarbamoyl-3 aminomethyl-5 oxazolidines ainsi que leurs sels avec des acides pharmacologiquement compatibles
EP88450019A EP0294307B1 (fr) 1987-05-14 1988-05-09 Arylcarbamoyl-3 aminométhyl-5 oxazolidines ainsi que leurs sels avec des acides pharmacologiquement compatibles
DE3850304T DE3850304T2 (de) 1987-05-14 1988-05-09 3-Arylcarbamoyl-5-aminomethyl-oxazolidine sowie deren Salz mit pharmakologisch verträglichen Säuren.
AT88450019T ATE107637T1 (de) 1987-05-14 1988-05-09 3-arylcarbamoyl-5-aminomethyl-oxazolidine sowie deren salz mit pharmakologisch verträglichen säuren.
ES88450019T ES2056121T3 (es) 1987-05-14 1988-05-09 3-arilcarbamoil-5-aminometil-oxazolidinas asi como sus sales con acidos farmaceuticamente compatibles.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8706890A FR2615190B1 (fr) 1987-05-14 1987-05-14 Nouvelles arylcarbamoyl-3 aminomethyl-5 oxazolidines ainsi que leurs sels avec des acides pharmaceutiquement compatibles, leur methode de preparation et leur application pharmaceutique

Publications (2)

Publication Number Publication Date
FR2615190A1 FR2615190A1 (fr) 1988-11-18
FR2615190B1 true FR2615190B1 (fr) 1989-07-21

Family

ID=9351162

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8706890A Expired FR2615190B1 (fr) 1987-05-14 1987-05-14 Nouvelles arylcarbamoyl-3 aminomethyl-5 oxazolidines ainsi que leurs sels avec des acides pharmaceutiquement compatibles, leur methode de preparation et leur application pharmaceutique

Country Status (1)

Country Link
FR (1) FR2615190B1 (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2226165A2 (en) * 1973-04-19 1974-11-15 Delalande Sa 3-Aminocarbonyl-5-phenyl-2-oxazolidones - with anticonvulsant, tranquillizing muscle relaxant, antiinflammatory and hypnotic activity
NZ194913A (en) * 1979-10-03 1983-11-18 Nippon Soda Co Trans-4,5-disubstituted-3-substituted (thio)carbamoyl-(oxazolidin or thiazolidin)-2-(thio)ones
PT77429B (fr) * 1982-10-05 1986-02-27 Cortial Procede pour preparer de nouvelles n-(amino-methyl-5 oxazolin-2 yl-2)n'-phenylurees et de compositions les contenant

Also Published As

Publication number Publication date
FR2615190A1 (fr) 1988-11-18

Similar Documents

Publication Publication Date Title
NO871408L (no) Forbedringer ved farmasoeytiske akseptable salter.
FR2635265B1 (fr) Composition pharmaceutique intraveineuse comprenant de la cyclosporine en tant que principe actif et procede pour sa preparation
NO882732D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
FR2586683B1 (fr) Nouveaux derives de neothramycine, leur procede de preparation et leur application en tant que medicaments
ATE83659T1 (de) Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus.
HUT43952A (en) Process for preparing pharmaceuticals comprising (-)-3-(3,4-dihydroxyphenyl)-l-alanine-methylester
DK208789D0 (da) Substituerede 4-(quinolin-2-yl-methoxy)-phenyleddikesyrer og estere deraf, deres fremstilling og anvendelse
NO885797L (no) Karboksylsyrederivater med terapeutisk virkning og fremgangsmaate til deres fremstilling.
IT1140521B (it) Sistema medicinale da somministrare per via intradermica per dinitrato di isosorbite
BE882764A (fr) Derives d'acide peneme-3-carboxylique, leurs procedes de preparation et leur application en therapeutique
DK381189A (da) N-2,3-butadienyl-tri- og -tetraaminoalkanderivater og deres anvendelse
IT8722501A0 (it) Formulazioni farmaceutiche per somministrazione transdermica.
DK561589A (da) Flydende oralt farmaceutisk praeparat
DK325289A (da) Strontiumsalt, fremgangsmaade til fremstilling heraf samt farmaceutiske midler indeholdende saltet
FR2615190B1 (fr) Nouvelles arylcarbamoyl-3 aminomethyl-5 oxazolidines ainsi que leurs sels avec des acides pharmaceutiquement compatibles, leur methode de preparation et leur application pharmaceutique
BR9807332A (pt) Antìgenos de leishmania para utilização na terapia e diagnóstico de leishmaniose
FR2449686B1 (fr) Nouvel ester de l'acide 1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetique et sa preparation, ainsi que medicament le comprenant et sa preparation
DK513188D0 (da) Aminosyreestre, deres fremstilling og anvendelse som laegemidler
DK0538690T3 (da) Arylquinolyl-substituerede 1,4-dihydropyridin-dicarboxylsyrederivater, fremgangsmåde til deres fremstilling af deres anvendelse i lægemidler
ES2081279T3 (es) Utilizacion de 15-desoxiespergualina como medicamento.
FR2617478B1 (fr) Nouveaux derives d'aryl-heteroaryl cetones, leur procede de preparation ainsi que leur application a titre de medicament
FR2583756B1 (fr) Procede de preparation des derives de la 2-halo-nicergoline et leurs sels d'addition avec des acides ainsi que des 2-halonicergolines nouvelles, compositions comportant des 2-halonicergolines et procede de preparation
DK299983D0 (da) Racemiske eller optisk aktive apovincaminsyrederivater eller farmaceutisk aktive syreadditionssalte deraf, deres fremstilling og anvendelse
DE3877747T2 (de) Glasartige matrize zur verabreichung von heilmitteln.
NO820180L (no) Basisk substituert antranilsyrer, fremgangsmaate til deres fremstilling og deres anvendelse

Legal Events

Date Code Title Description
ST Notification of lapse